Liberty Biopharma (CVE:LTY) Stock Crosses Above Fifty Day Moving Average – Should You Sell?
by Scott Moore · The Cerbat GemLiberty Biopharma Inc (CVE:LTY – Get Free Report) shares crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.
Liberty Biopharma Price Performance
The company’s 50-day moving average is C$2.00 and its two-hundred day moving average is C$2.00. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.12 and a quick ratio of 0.12. The firm has a market cap of C$21.54 million and a P/E ratio of -12.66.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.